Complement activation products in idiopathic pulmonary fibrosis: Relevance of fragment Ba to disease severity
- 1 October 1990
- journal article
- research article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 57 (1) , 64-73
- https://doi.org/10.1016/0090-1229(90)90022-i
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?Journal of Clinical Pathology, 1989
- Clinical application of new technique that measures C4d for assessment of activation of classical complement pathway.Journal of Clinical Pathology, 1988
- Activation of the alternative complement pathway: clinical application of a new technique to measure fragment Ba.Journal of Clinical Pathology, 1987
- A Clinical, Radiographic, and Physiologic Scoring System for the Longitudinal Assessment of Patients with Idiopathic Pulmonary Fibrosis1–3American Review of Respiratory Disease, 1986
- Clinical application of a new nephelometric technique to measure complement activation.Journal of Clinical Pathology, 1983
- Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4A and C4B in determining disease susceptibility.BMJ, 1983
- Idiopathic Pulmonary FibrosisArchives of internal medicine (1960), 1981
- Angiotensin-I-Converting Enzyme and Gallium Scan in Noninvasive Evaluation of SarcoidosisAnnals of Internal Medicine, 1979
- Circulating Immune Complexes in the Idiopathic Interstitial PneumoniasNew England Journal of Medicine, 1978
- Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis.Journal of Clinical Investigation, 1977